Dr. Carlsson to present keynote speech at CTAD conference

Dr Carlsson

Wisconsin Alzheimer’s Institute Director Cynthia Carlsson, MD, MS, is a keynote presenter at the upcoming Clinical Trials on Alzheimer’s Disease (CTAD) conference. The 14th annual CTAD conference, Therapeutic Trials in AD: A New Hope for 2022?, is November 9 -12, 2021 with a combined in-person meeting in Boston and a digital platform.

Dr. Carlsson’s talk is titled “Vascular Risk Factors and Alzheimer’s Disease: Implications for Clinical Trials.”

CTAD is an meeting focused on Alzheimer’s Disease Therapeutic Trials with prominent leaders in Alzheimer Disease research convening and forming partnerships with the objective of speeding the development of effective treatments to fight the disease. Find out more about the event on the CTAD website.